SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-005919
Filing Date
2024-08-19
Accepted
2024-08-19 17:25:36
Documents
15
Period of Report
2024-08-19
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K actuate_8k.htm   iXBRL 8-K 33961
2 LETTER FROM CPA actuate_ex1601.htm EX-16.1 2382
  Complete submission text file 0001683168-24-005919.txt   240951

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE actu-20240819.xsd EX-101.SCH 3106
4 XBRL DEFINITION FILE actu-20240819_def.xml EX-101.DEF 26226
5 XBRL LABEL FILE actu-20240819_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE actu-20240819_pre.xml EX-101.PRE 22381
17 EXTRACTED XBRL INSTANCE DOCUMENT actuate_8k_htm.xml XML 3803
Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 847-986-4190
ACTUATE THERAPEUTICS, INC. (Filer) CIK: 0001652935 (see all company filings)

IRS No.: 473044785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42139 | Film No.: 241221760
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)